(Q38106633)

29 August 2017

Insulin resistance: an emerging link in Alzheimer's disease (English)

1 reference

29 August 2017

0 references

1 reference

Bikash Medhi

1

1 reference

PubMed ID

23670236

29 August 2017

Mrinmoy Chakrabarty

series ordinal

2

1 reference

29 August 2017

14 May 2013

1 reference

29 August 2017

Neurological Sciences

1 reference

29 August 2017

34

1 reference

29 August 2017

10

1 reference

29 August 2017

1719-1725

1 reference

https://scigraph.springernature.com/pub.10.1007/s10072-013-1454-1

29 August 2017

0 references

cites work

Forecasting the global burden of Alzheimer’s disease

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1454-1

Peripheral insulin and brain structure in early Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1454-1

Insulin receptors are widely distributed in human brain and bind human and porcine insulin with equal affinity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1454-1

Effect of altered nutritional states on insulin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1454-1

The insulin-like growth factor system and its pleiotropic functions in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1454-1

The F-box protein Cdc4/Fbxw7 is a novel regulator of neural crest development in Xenopus laevis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1454-1

Permissive role of insulin in the expression of long-term potentiation in the hippocampus of immature rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1454-1

Insulin deficiency exacerbates cerebral amyloidosis and behavioral deficits in an Alzheimer transgenic mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1454-1

Deficient brain insulin signalling pathway in Alzheimer's disease and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1454-1

Does insulin dysfunction play a role in Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1454-1

Insulin signaling in the central nervous system: learning to survive

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1454-1

Molecular mechanisms of insulin receptor substrate protein-mediated modulation of insulin signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1454-1

Glucose transporter expression in the central nervous system: relationship to synaptic function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1454-1

Selective small-molecule inhibitors of glycogen synthase kinase-3 activity protect primary neurones from death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1454-1

GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1454-1

Postsynaptic signaling and plasticity mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1454-1

Cognitive effects of insulin in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1454-1

Insulin and the insulin receptor in experimental models of learning and memory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1454-1

Impaired insulin-induced vasodilation in small coronary arteries of Zucker obese rats is mediated by reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1454-1

The role of metabolic disorders in Alzheimer disease and vascular dementia: two roads converged

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1454-1

Role of insulin and insulin receptor in learning and memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1454-1

Insulin receptor signaling in long-term memory consolidation following spatial learning

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1454-1

Role for neuronal insulin resistance in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1454-1

The worldwide epidemiology of type 2 diabetes mellitus--present and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1454-1

Diabetes and cognitive dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1454-1

Impaired insulin secretion increases the risk of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1454-1

Comorbid type 2 diabetes mellitus and hypertension exacerbates cognitive decline: evidence from a longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1454-1

Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1454-1

Prediabetes in obese youth: a syndrome of impaired glucose tolerance, severe insulin resistance, and altered myocellular and abdominal fat partitioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1454-1

Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1454-1

Insulin resistance and hippocampal volume in women at risk for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1454-1

Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1454-1

Advanced glycation end products and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1454-1

Decreased clearance of CNS beta-amyloid in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1454-1

Alzheimer's disease and blood-brain barrier function-Why have anti-beta-amyloid therapies failed to prevent dementia progression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1454-1

Deposition of Alzheimer's beta-amyloid is inversely correlated with P-glycoprotein expression in the brains of elderly non-demented humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1454-1

P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1454-1

The recent updates of therapeutic approaches against aβ for the treatment of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1454-1

Brain neprilysin activity and susceptibility to transgene-induced Alzheimer amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1454-1

Age-dependent decline of neprilysin in Alzheimer's disease and normal brain: inverse correlation with A beta levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1454-1

Mechanisms underlying insulin deficiency-induced acceleration of β-amyloidosis in a mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1454-1

Positron emission tomographic (PET) studies in dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1454-1

A gene expression profile of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1454-1

Insulin and insulin-like growth factor-1 regulate tau phosphorylation in cultured human neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1454-1

O-GlcNAc: a regulatory post-translational modification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1454-1

Brain structure in healthy adults is related to serum transferrin and the H63D polymorphism in the HFE gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1454-1

A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1454-1

The role of iron in diabetes and its complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1454-1

Association among serum ferritin, alanine aminotransferase levels, and metabolic syndrome in Korean postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1454-1

Signal transduction by the JNK group of MAP kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1454-1

JNK3 perpetuates metabolic stress induced by Aβ peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1454-1

Insulin in central nervous system: more than just a peripheral hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1454-1

Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1454-1

Transferrinuria in Type 2 Diabetes: The Effect of Glycaemic Control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1454-1

A Prospective Study of Plasma Ferritin Level and Incident Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1454-1

The c-Jun N-terminal kinase JNK participates in cytokine- and isolation stress-induced rat pancreatic islet apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-013-1454-1

Insulin elicits a redistribution of transferrin receptors in 3T3-L1 adipocytes through an increase in the rate constant for receptor externalization.

21 January 2018

1 reference

12 December 2020

Central insulin resistance as a trigger for sporadic Alzheimer-like pathology: an experimental approach

1 reference

12 December 2020

Intracerebroventricular administration of betacytotoxics alters expression of brain monoamine transporter genes

1 reference

12 December 2020

Alzheimer’s drugs take a new tack

1 reference

12 December 2020

Insulin receptor signaling in the development of neuronal structure and function.

1 reference

12 December 2020

Selective interaction of JNK protein kinase isoforms with transcription factors

1 reference

12 December 2020

Stimulation of beta-amyloid precursor protein trafficking by insulin reduces intraneuronal beta-amyloid and requires mitogen-activated protein kinase signaling.

1 reference

12 December 2020

Impaired brain glucose metabolism leads to Alzheimer neurofibrillary degeneration through a decrease in tau O-GlcNAcylation.

1 reference

12 December 2020

Glycogen synthase kinase 3β is identical to tau protein kinase I generating several epitopes of paired helical filaments

1 reference

12 December 2020

An integrated and unifying hypothesis for the metabolic basis of sporadic Alzheimer's disease

1 reference

12 December 2020

10.1007/S10072-013-1454-1

Identifiers

DOI

1 reference

29 August 2017

1 reference

PubMed ID

23670236